26.00USD-1.48%Mkt Cap: —P/E: —1d ago
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconst…
Industry Peers
MachineryKey Statistics
Company
Market Cap—
Enterprise Value2.86B $
Revenue (TTM)2.30B $
Gross Profit1.41B $
Net Income (TTM)-1.10B $
Revenue/Share40.07 USD
Last Price26.00 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees7.8K
CountryGB
SectorIndustrials
IndustryMachinery
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA7.54
EV/Revenue1.24
P/S—
P/B1.02
EPS (TTM)—
EPS (Forward)—
52W Range
25.1055% of range26.74
52W High26.74 USD
52W Low25.10 USD
Profitability
Gross Margin61.32%
Oper. Margin4.18%
EBITDA Margin16.51%
Profit Margin-47.97%
ROE-54.14%
ROA1.19%
Growth
Revenue Growth3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF270.10M $
CapEx (TTM)—
FCF Margin8.08%
FCF Yield—
Net Debt1.36B $
Net Debt/EBITDA3.58
Balance Sheet
Debt/Equity92.56
Current Ratio1.99
Quick Ratio0.74
Book Value/Sh25.61 USD
Cash/Share0.2180 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.333333:1
Split DateApr 5, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float52.79M
Insiders1.62%
Institutions124.96%
Technical
SMA 5056.19 (-53.7%)
SMA 20054.68 (-52.4%)
Beta1.45
S&P 52W Chg18.16%
Avg Vol (30d)73
Avg Vol (10d)36
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—